Hanny Al-Samkari, M.D.

Job Title: 
Co-Director, MGH HHT Center
Treatments or Procedures Provided: 
Bevacizumab IV
Iron Therapy IV
Other AVM Treatment
Other Drug Therapy (for Bleeding/Symptomatic Liver Vascular Malformations)
Conditions Treated: 
Anemia/Iron Deficiency
Nosebleeds (Epistaxis)
Gastrointestinal (GI) Bleeding
Gastrointestinal (GI) AVMs/Telangiectasias
Other AVMs
Language Spoken: 
55 Fruit St.
Boston, MA 02215
United States
Scheduling Contact
(617) 726-8748
Education & Facts
Board Certification: 
American Board of Internal Medicine
Residency Program:
Hospital of the University of Pennsylvania - 2014
Dr. Al-Samkari is Co-Director of the Massachusetts General Hospital HHT Center of Excellence and an Associate Professor of Medicine at Harvard Medical School. He is a hematologist who specializes in bleeding and clotting disorders, with a specific focus in bleeding disorders and HHT. In addition to management of bleeding, he specializes in management of anemia associated with HHT, typically due to severe and often refractory iron deficiency. He has seen and treated several hundred patients with HHT with bleeding and/or anemia. He is a recognized leader in investigation and clinical treatment of the treatment of HHT with anti-angiogenic therapies, including bevacizumab (Avastin), pomalidomide, pazopanib, VAD044 and others.
55 Fruit St.
Boston, MA 02215
United States
Last Updated: September 1, 2023
Go to top